ESLOF:OTC-EssilorLuxottica Société anonyme (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 213.25

Change

0.00 (0.00)%

Market Cap

USD 104.29B

Volume

552.00

Analyst Target

USD 160.21
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ESLOY Essilor International SA

N/A

USD 101.63B
HOCPF HOYA Corporation

N/A

USD 40.96B
HOCPY Hoya Corp

N/A

USD 40.66B
RSMDF Resmed Inc DRC

N/A

USD 31.10B
CLPBF Coloplast A/S

N/A

USD 27.05B
CLPBY Coloplast A

N/A

USD 26.98B
TRUMF Terumo Corporation

N/A

USD 26.03B
TRUMY Terumo Corp ADR

N/A

USD 24.81B
SAUHF Straumann Holding AG

N/A

USD 21.26B
SRTOY Sartorius Stedim Biotech S.A

N/A

USD 21.15B

ETFs Containing ESLOF

C068:F 2.63 % 0.00 %

N/A

N/A
C068:XETRA 2.63 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.05% 76% C+ 63% D
Dividend Return 2.14% 89% A- 46% F
Total Return 9.19% 74% C 64% D
Trailing 12 Months  
Capital Gain 13.32% 83% B 72% C
Dividend Return 2.26% 62% D 31% F
Total Return 15.58% 80% B- 71% C-
Trailing 5 Years  
Capital Gain 80.49% 96% N/A 85% B
Dividend Return 11.10% 59% D- 37% F
Total Return 91.59% 92% A 85% B
Average Annual (5 Year Horizon)  
Capital Gain 11.77% 59% D- 58% F
Dividend Return 13.18% 57% F 56% F
Total Return 1.41% 54% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 21.95% 88% B+ 83% B
Risk Adjusted Return 60.04% 96% N/A 91% A-
Market Capitalization 104.29B 100% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.